Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Wuerzburg University Hospital
Recent studies involving continuous, 24-hour intraocular pressure (IOP) monitoring in glaucoma patients linked IOP variation to disease progression.
No study has previously compared the postoperative IOP variation of microshunt (Preserflo, P) implantation to ab interno trabeculectomy (Trabectome, T).
In this prospective cohort, the investigators analyzed 68 patients (34 P and 34 T) who presented for 24-hour IOP monitoring 6 to 12 months after surgery. Surgery must have been conducted between October 2020 and July 2021. Patients were assigned to each study group according to the intervention undergone, P or T. IOP and tonographic outflow facility were measured in the habitual position using a pneumatonometer. The IOP variation was considered the primary outcome measure.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients that have undergone microshunt implantation or ab interno trabeculectomy between 6-12 months ago
patients suffering from open-angle glaucoma
You may not be if
Patients that have undergone microshunt implantation or ab interno trabeculectomy less than 6 months or over 12 months ago